Periodontal Engineering Using Biomimetic Nano Scaffolds

描述(申请人提供)：牙周炎会导致牙齿支持组织的丢失，包括骨、牙骨质和牙周膜(PDL)，如果不治疗，最终会导致牙齿脱落。牙齿组织丢失是仅次于输血的第二大患者群体。用目前的治疗方法，这些支持牙齿的缺陷可以在一定程度上得到修复，但结果往往令人失望。当生长因子输送到牙周骨病变时，会刺激骨骼和软组织的修复。然而，人体试验在促进再生方面未能显示出一致的结果。在我们最初的资助期间，我们已经证明了BMP7(成骨诱导)和PDGF(血管生成和有丝分裂生成)等生长因子的传递方式和协调对牙槽骨缺损的组织工程至关重要。牙周病的特点是牙周过程的慢性和炎症性。然而，目前的牙周组织工程技术只关注单一的再生因子或细胞的使用，而没有解决宿主对污染微生物区系的反应或影响。不仅可以控制组织新生的再生过程，而且可以解决旺盛的炎症反应和微生物感染的方法可能是有价值的。在这个相互竞争的更新建议中，我们假设慢性炎症性牙周病变的强劲再生可以通过生长因子增强的生物活性支架来协调再生活性与抗基质金属蛋白酶(MMP)和抗微生物活性。对于我们的研究，我们提出了以下具体目标：SA 1.开发纳米纤维支架中的纳米球，用于控制局部释放基质金属蛋白酶抑制/抗菌剂。SA 2.开发三重负载纳米球的纳米纤维支架，以输送PDGF、BMP7和基质金属蛋白酶抑制/抗菌剂；并优化其释放曲线的组合，以最大限度地促进体内牙周再生。SA 3.证实根据AIMS 1和AIMS 2的结果选择的纳米球/纳米纤维支架为慢性病原体诱导的牙周创伤模型中的牙周组织再生提供了优越的环境。 公共卫生相关性：由于牙周炎的慢性炎症性质，美国超过50%的成年人患有牙周炎，没有可预测的治疗结果，其中约10%的人表现出严重疾病并伴有早期牙齿脱落。该项目将极大地提高我们设计修复牙周炎引起的牙周创伤的方法的能力，从而导致先进的新的再生疗法。

DESCRIPTION (provided by applicant): Periodontitis results in loss of tooth-supporting tissues including bone, cementum, and periodontal ligament (PDL), ultimately leading to tooth loss if left untreated. Dental tissue loss represents the second largest patient population next to blood transfusion. With current therapies, these tooth-supporting defects can be repaired to some degree, but the results are often disappointing. Growth factors stimulate bone and soft tissue repair when delivered to periodontal bone lesions. However, human trials have failed to show consistent results in promoting regeneration. During our initial grant period, we have demonstrated that the mode of delivery and the coordination of growth factors such as BMP7 (osteoinductive) and PDGF (angiogenic and mitogenic) are critical for tissue engineering of alveolar bone defects. The hallmark of periodontal disease is the chronic and inflammatory nature of the process. However, current technologies for periodontal tissue engineering have only focused on the use of singular regenerative factors or cells, without addressing the host response or influence of contaminating microbiota. Approaches that can not only control the regenerative processes of tissue neogenesis, but also address exuberant inflammatory responses and microbial infection may be valuable. In this competing renewal proposal, we hypothesize that the robust regeneration of chronic inflammatory periodontal lesions can be achieved by coordinating the regenerative activities with the anti- matrix metalloproteinase (MMP) and anti-microbial activities via a growth factor-enhanced bioactive scaffold. For our studies, the following specific aims are proposed: SA 1. Develop nanospheres incorporated into nano-fibrous scaffolds for controlled local delivery of MMP- inhibitory/antimicrobial agents. SA 2. Develop nano-fibrous scaffold with triple-loaded nanospheres to deliver PDGF, BMP7, and MMP- inhibitory/antimicrobial agents; and optimize the combination of their release profiles to maximize periodontal regeneration in vivo. SA 3. Confirm that the nanosphere/nano-fibrous scaffold, selected based on the results from aims 1 and 2, provides a superior environment for regeneration of periodontal tissues in chronic pathogen-induced periodontal wound models. PUBLIC HEALTH RELEVANCE: Periodontitis afflicts over 50% of the adult population in the United States without a predictable treatment outcome due to its chronic inflammatory nature, with approximately 10% displaying severe disease concomitant with early tooth loss. This project should significantly advance our capacity to design a modality for restoring periodontal wounds resulted from periodontitis, leading to advanced new regenerative therapies.